| 1 | EVL
|
| Molecular mechanism of Ena/VASP-mediated actin-filament elongation.
|
| Breitsprecher D, Kiesewetter AK, Linkner J, Vinzenz M, Stradal TE, Small JV, Curth U, Dickinson RB, Faix J.
|
| EMBO J 30(3):456-67. Epub 2011 Jan 7.
2011
|
| 2 | EVL, RAD51, RAD51B
|
| Recombination activator function of the novel RAD51- and RAD51B-binding protein, human EVL.
|
| Takaku M, Machida S, Hosoya N, Nakayama S, Takizawa Y, Sakane I, Shibata T, Miyagawa K, Kurumizaka H.
|
| J Biol Chem 284(21):14326-36. Epub 2009 Mar 26. 2009
|
| 3 | EVL
|
| EVL (Ena/VASP-like) expression is up-regulated in human breast cancer and its relative expression level is correlated with clinical stages.
|
| Hu LD, Zou HF, Zhan SX, Cao KM.
|
| Oncol Rep 19(4):1015-20.
2008
|
| 4 | EVL
|
| Spectrin interacts with EVL (Enabled/vasodilator-stimulated phosphoprotein-like protein), a protein involved in actin polymerization.
|
| Bournier O, Kroviarski Y, Rotter B, Nicolas G, Lecomte MC, Dhermy D.
|
| Biol Cell 98(5):279-93.
2006
|
| 5 | EVL, SPTAN1, TES
|
| AlphaII-spectrin interacts with Tes and EVL, two actin-binding proteins located at cell contacts.
|
| Rotter B, Bournier O, Nicolas G, Dhermy D, Lecomte MC.
|
| Biochem J 388(Pt 2):631-8. 2005
|